SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,309.03 |
| Enterprise Value ($M) | 1,101.86 |
| Book Value ($M) | 535.31 |
| Book Value / Share | 7.74 |
| Price / Book | 2.45 |
| NCAV ($M) | 515.00 |
| NCAV / Share | 7.45 |
| Price / NCAV | 2.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.27 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | -0.50 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 29.27 |
| Current Ratio | 29.27 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 559.96 |
| Assets | 580.27 |
| Liabilities | 44.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -172.87 |
| Net Income | -151.76 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -145.37 |
| Cash from Investing | -223.62 |
| Cash from Financing | 353.32 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | General Atlantic Llc | 7.70 | ||
| 13G | Price T Rowe Associates Inc /md/ | 6.60 | 53.32 | |
| 13G/A | Pfizer Inc | 4.53 | 0.00 | |
| 13G | Rtw Investments, Lp | 6.40 | ||
| 13G/A | Baker Bros. Advisors Lp | 4.30 | 0.00 | |
| 13G/A | Redmile Group, LLC | 2.00 | -57.86 | |
| 13G/A | Avidity Partners Management LP | 0.40 | -93.86 | |
| 13G/A | Alkeon Capital Management Llc | 6.80 | 16.04 | |
| 13G/A | Janus Henderson Group Plc | 7.70 | 28.93 | |
| 13G | Vanguard Group Inc | 5.54 | ||
| 13G | Wellington Management Group Llp | 5.17 | 228.96 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 0.49 | -90.19 | |
| 13G/A | BlackRock Inc. | 7.50 | 51.55 | |
| 13G/A | State Street Corp | 9.20 | 104.84 | |
| 13G/A | Skorpios Trust | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| 33 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| 33 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| 33 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 108,286 | 400,217 | 27.06 | |
| 121,850 | 373,830 | 32.60 | |
| 55,613 | 274,822 | 20.24 | |
| 102,460 | 260,943 | 39.27 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACT – Enact Holdings, Inc. | ADPT – Adaptive Biotechnologies Corporation |
| AGIO – Agios Pharmaceuticals, Inc. | ALEC – Alector, Inc. |
| ALKS – Alkermes plc |
Financial data and stock pages provided by
Fintel.io